Home/ Stocks/ PACB

Pacific Biosciences of California, Inc.

PACB XNAS

$1.19 +0.02 (+1.30%) ▲ 15-min delayed

Open

$1.19

High

$1.23

Low

$1.17

Volume

7.36M

Market Cap

$361.85M

About Pacific Biosciences of California, Inc.

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.

Sector: LABORATORY ANALYTICAL INSTRUMENTS Employees: 485 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$37.18M	$-8,275,000	$-0.03
FY 2025	$160.00M	$-546,376,000	$-1.82
Q3 2025	$38.44M	$-38,000,000	$-0.13
Q2 2025	$39.77M	$-41,930,000	$-0.14

Earnings & Analyst Ratings

Next Earnings: Tue, Nov 3, 2026

Calendar →

Related Market News

No specific coverage for PACB yet. Check out our latest market news or earnings calendar.

Get PACB Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Pacific Biosciences of California, Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.